- ¥380 - 3800
- 百奥莱博
- M03535-FMR
- 北京
- 2025年07月15日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 库存：
275
- 英文名：
R-1479
- CAS号：
478182-28-4
- 保质期：
2年
- 供应商：
北京百奥莱博科技有限公司
- 保存条件：
-20℃，有效期2年，溶入溶剂后-20℃
- 规格：
1mL(10mM)|2mg|5mg|10mg|50mg|100mg
特别提示：包括HCV replication抑制剂（R-1479）在内，本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！
产品名称：HCV replication抑制剂（R-1479）
英文名称：R-1479
产品货号：M03535
产品规格：1mL(10mM)|2mg|5mg|10mg|50mg|100mg
R-1479是一种特异性的HCV复制(HCV replication)抑制剂，在HCV亚基因组复制体系中，IC50为1.28μM。
注：本品仅可用于科研实验，严禁用于临床医疗及其他用途！
CAS号：478182-28-4
别名：4-Azidocytidine
纯度：99.44%
分子式：C₉H₁₂N₆O₅
分子量：284.23
结构式：
储存条件：-20℃，有效期2年，溶入溶剂后-20℃请尽量在一个月内使用。
除了HCV replication抑制剂（R-1479）,4-Azidocytidine，我公司还供应以下相关产品：
| 货号 | 名称 | 规格 |
| KFS296 | LY294002(PI3K抑制剂) | 1mg |
| M00507 | Wnt信号激活剂(BML-284) | 1mL(10mM)|5mg|10mg|50mg|100mg|200mg |
| M00544 | IAPs抑制剂(GDC-0152) | 1mL(10mM)|10mg|50mg |
| M00666 | PDE8抑制剂(PF-04957325) | 1mL(10mM)|1mg|5mg|10mg|50mg|100mg |
| M01252 | EGFR和ErbB2抑制剂(AST-1306 TsOH) | 1mL(10mM)|2mg|5mg|10mg|50mg |
| M01577 | 转酮醇酶(TK)抑制剂（N3PT） | 1mL(10mM)|5mg|10mg|50mg|100mg |
| M01889 | PARP2抑制剂(UPF 1069) | 1mL(10mM)|10mg|50mg |
| M02035 | GRK抑制剂（CCG215022） | 1mL(10mM)|1mg|5mg|10mg|50mg|100mg |
| M02543 | SIRT2抑制剂(AGK2) | 1mL(10mM)|5mg|10mg|25mg |
| M02627 | PLA2激活剂(Melittin) | 1mL(10mM)|1mg|5mg|10mg |
| M02768 | calcium channel抑制剂（Mibefradil dihydrochloride） | 1mL(10mM)|5mg|10mg|50mg |
| M02805 | HMG-CoA还原酶抑制剂（Pravastatin sodium） | 1mL(10mM)|10mg|50mg|100mg|200mg |
| M03877 | HCV聚合酶抑制剂(VX-222) | 1mL(10mM)|5mg|10mg|50mg |
| M04253 | HCVRNA复制抑制剂(Sofosbuvir impurity I) | 1mL(10mM)|1mg|5mg |
| M04462 | IκB激酶(IKK)抑制剂(IKK 16) | 1mL(10mM)|10mg|50mg |
| M04608 | autotaxin(ATX)抑制剂(GLPG1690) | 1mL(10mM)|5mg|10mg|25mg|50mg|100mg |
| M04716 | Btk抑制剂(PCI 29732) | 1mL(10mM)|2mg|5mg|10mg|50mg|100mg |
| M05628 | 纤溶酶原激活剂（6-Aminocaproic acid） | 1mL(10mM)|50mg|100mg |
| M05792 | γ-secretase抑制剂(LY-411575) | 1mL(10mM)|5mg|10mg|50mg|100mg |
| M06782 | 乙酰胆碱酯酶抑制剂(Corydaline) | 1mL(10mM)|5mg|10mg |
| M08151 | α1repector抑制剂 | 1mL(10mM)|100mg|500mg |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Studying HCV Cell Entry with HCV Pseudoparticles (HCVpp)
side effects. Although about 300 million people worldwide are estimated to be infected, the characterization of HCV biology and associated pathologies and development of new therapeutics have been slow. Systems that support HCV replication and particle
Simultaneous Detection of Anti-HCV Antibody and HCV Core Antigen
HCV infection is usually diagnosed by means of an enzyme immune assay for the detection of antibody against HCV. The window period between infection and seroconversion remains a dramatic problem in the transfusional and diagnostic setting
The AMPLICOR HCV Tests for the Detection and Quantitation of Serum or Plasma HCV RNA
Clinical diagnosis of HCV infection is generally accomplished by using immunoserological assays to detect the presence of anti-HCV antibodies. Such immunoserological assays have been approved for blood donor screening, thereby reducing
技术资料暂无技术资料 索取技术资料
